New Legal Pathway for Biosimilars Creates Opportunities and Challenges For Biological Manufacturers — A Guide To The Legislation
June 14, 2010
Foley Partners Jacqueline Wright Bonilla and Nathan Beaver authored an article that appeared in the June 2010 issue of Bloomberg’s Health Law Report titled “New Legal Pathway for Biosimilars Creates Opportunities and Challenges For Biological Manufacturers — A Guide To The Legislation.”
Author(s)
Related Insights
June 17, 2026
Foley Viewpoints
What the New Executive Order on AI and Cybersecurity Means for Your Business
On June 2, 2026, the White House issued a new Executive Order titled “Promoting Advanced Artificial Intelligence Innovation and Security.” The order arrives at a moment of significant public attention to the capabilities of next-generation AI systems and the cybersecurity risks they may present.
June 17, 2026
Foley Career Perspectives
Foley Pride Month Program: Developing Advanced Ally Skills
In honor of Pride Month, Foley & Lardner welcomed back PFLAG National for the sixth year in a row to help us continue to advance in our journey of allyship. This year’s virtual workshop for all firm members, titled “So What’s Next? Developing Advanced Ally Skills,” was held on June 9 and led by PFLAG Vice President of Learning & Inclusion Jamie Henkel (she/her).
June 17, 2026
Foley Viewpoints
California Court of Appeal Highlights Licensing Risk for Equipment Suppliers and Installers
A newly published California decision, AVL Test Systems, Inc. v. Hensel Phelps Construction Co. (Cal. Ct. App. Apr. 28, 2026), is worth close attention for contractors, specialty trades, equipment suppliers, and anyone operating in the gray area between “supplying equipment” and “performing construction.”